AbClon Inc (174900) - Total Liabilities

Latest as of September 2025: ₩9.44 Billion KRW ≈ $6.40 Million USD

Based on the latest financial reports, AbClon Inc (174900) has total liabilities worth ₩9.44 Billion KRW (≈ $6.40 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore AbClon Inc (174900) cash conversion ratio to assess how effectively this company generates cash.

AbClon Inc - Total Liabilities Trend (2015–2024)

This chart illustrates how AbClon Inc's total liabilities have evolved over time, based on quarterly financial data. Check 174900 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

AbClon Inc Competitors by Total Liabilities

The table below lists competitors of AbClon Inc ranked by their total liabilities.

Company	Country	Total Liabilities
China Railway Harbin Group of Technology Corp. A SHG:688459	China	CN¥618.18 Million
Bajaj Consumer Care Limited NSE:BAJAJCON	India	Rs2.00 Billion
Matrix Concepts Holdings Bhd KLSE:5236	Malaysia	RM1.18 Billion
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited STU:2TZ	Germany	€4.59 Billion
Shenzhen Water Planning & Design Institute Co. Ltd. SHE:301038	China	CN¥968.74 Million
E&R Engineering TWO:8027	Taiwan	NT$1.49 Billion
BlackRock Utility & Infrastructure Trust NYSE:BUI	USA	$805.10K
Zhejiang Gongdong Medical Technology Co Ltd SHG:605369	China	CN¥393.21 Million

Liability Composition Analysis (2015–2024)

This chart breaks down AbClon Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AbClon Inc (174900) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.61	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AbClon Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AbClon Inc (2015–2024)

The table below shows the annual total liabilities of AbClon Inc from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩18.78 Billion ≈ $12.72 Million	+3.24%
2023-12-31	₩18.19 Billion ≈ $12.33 Million	+4.18%
2022-12-31	₩17.46 Billion ≈ $11.83 Million	+66.76%
2021-12-31	₩10.47 Billion ≈ $7.09 Million	-3.07%
2020-12-31	₩10.80 Billion ≈ $7.32 Million	-6.81%
2019-12-31	₩11.59 Billion ≈ $7.85 Million	+15.84%
2018-12-31	₩10.00 Billion ≈ $6.78 Million	+188.10%
2017-12-31	₩3.47 Billion ≈ $2.35 Million	-13.84%
2016-12-31	₩4.03 Billion ≈ $2.73 Million	+40.95%
2015-12-31	₩2.86 Billion ≈ $1.94 Million	--

About AbClon Inc

KQ:174900 Korea Biotechnology

Market Cap

$635.95 Million

₩938.42 Billion KRW

Market Cap Rank

#11309 Global

#346 in Korea

Share Price

₩49150.00

Change (1 day)

-2.48%

52-Week Range

₩9630.00 - ₩89100.00

All Time High

₩90600.00